An inhaler only works when the patient uses it right and refills it on time.
Inhaler technique errors and lapsed controller refills are among the most common and most invisible drivers of COPD exacerbations. Every exacerbation that ends in a readmission lands on quality and cost measures tied to your practice. Fairview Pharmacy holds an EQuIPP star rating of 5.00 from Elevate Provider Network, Quarter 4, 2025, and we coach technique and keep refills on schedule.
What happens after the prescription
The device is only as good as the technique behind it.
A controller inhaler prescribed correctly still fails if the patient uses the device wrong, and inhaler technique errors are very common in COPD. Add a lapsed controller refill, a prior authorization that stalls, or a cost barrier, and exacerbations follow. Many COPD readmissions trace back to exactly these preventable gaps, and they are invisible to you until the patient is back in the hospital.
A chain pharmacy hands the patient an inhaler and never watches them use it. Fairview does.
Pulmonary specific quality risk
Every preventable exacerbation moves a measure the wrong way.
COPD 30 day readmissions
An exacerbation that ends in readmission counts against the readmission and cost measures tied to your panel and your value based contracts.
MIPS quality and cost, respiratory measure set
Poorly controlled COPD and asthma patients generate crisis visits and admissions that are associated with lower MIPS quality and cost scores. MIPS adjustments can reach up to 9 percent, a maximum.
Controller medication adherence
Health plans track controller inhaler adherence. A patient who lapses or misuses the device pulls that score down across every plan they belong to.
A pharmacy that hands over an inhaler with no technique check is leaving your readmission score exposed. A pharmacy measured and published on adherence closes that gap.
The gap behind a readmission
At a chain pharmacy, your COPD patient gets an inhaler and no technique check at all.
Nobody watches them use the device. Nobody catches a lapsed controller refill. Nobody calls when a prior authorization stalls. You find out when the exacerbation becomes an admission that lands on your readmission score.
That is not a pharmacy partner. That is a liability sitting between you and your quality measures.
EQuIPP verified, all four measures published
Fairview coaches technique and keeps controller refills on schedule.
EQuIPP star measures, Elevate Provider Network. Quarter 4, 2025, closed measurement year.
- Blood pressure (RASA) PDC98.2%, 215 of 219 patients5 stars
- Cholesterol PDC97.2%, 246 of 253 patients5 stars
- Statin use in diabetes96.3%, 52 of 54 patients5 stars
- Diabetes PDC95.6%, 108 of 113 patients5 stars
EQuIPP star rating 5.00. Five stars on all four measures, every year since 2022.
Fairview's EQuIPP star measure performance, issued by Elevate Provider Network for the closed 2025 measurement year: Blood pressure (RASA) PDC 98.2%, 215 of 219 patients. Cholesterol PDC 97.2%, 246 of 253. Statin use in diabetes 96.3%, 52 of 54. Diabetes PDC 95.6%, 108 of 113. EQuIPP star rating 5.00. Five stars on all four measures, every year since 2022. For your COPD and asthma patients, that discipline means hands on inhaler technique coaching, controller refills kept on schedule, and a pharmacist who closes the loop before an exacerbation becomes a readmission.
EQuIPP performance metrics as of Quarter 4, 2025, Medicare Part D population, benchmarked against national pharmacy averages. These measures describe prescribing and dispensing patterns. Neither is a measure of health outcomes.
You prescribe.
E prescribe to Fairview. NCPDP 2515104, NPI 1144383613.
We fill same day.
We clear every prior authorization, including inhaler and biologic prior authorizations.
We coach technique.
We watch patients use the device and call before controller refills lapse.
We report to you.
A one page adherence report at day ninety on the patients you referred.
You reinforce.
You address control at the next visit.
Same day fills
Every inhaler and respiratory prescription filled within 24 hours.
100% prior authorization handling
We carry the full inhaler and biologic prior authorization burden for your staff.
Inhaler technique coaching
We watch every patient use the device and correct the errors.
Controller refill tracking
We synchronize controller inhalers and call before any refill lapses.
A one page report at day ninety
Who is on track and who is not, delivered at day ninety.
Direct clinical line
Your patients call us about technique and cost, not your nurses.
Start with 5, zero risk
Send us 5 of your highest risk COPD patients. 90 days. Zero risk.
We coach inhaler technique, keep every controller refill on time, and report adherence back to your office. No contract, no cost, and nothing owed in either direction. If the reports are not useful, tell us and we will change the format.
Request your intro call
A 10 minute call with Dr. Mike, no commitment and no paperwork to start. Just tell us how to reach you and a little about your practice. The 5 patient pilot is what we walk through on the call.
Typical response: Within 1 business day
Forms for referring practices